Authors


Joanna Lorenz

Latest:

Cognitive Disorders are a Risk Factor for Severe COVID-19

Alzheimer’s disease, dementia, and genetic variations in areas key to viral infection are risk factors for severe COVID-19 a new study suggests.


ANNE BORJA, MD

Latest:

Cryptosporidium: A Potentially Fatal Cause of Diarrhea in a Heart Transplant Recipient

Expanding the differential for diarrhea beyond Clostridium difficile.


Payal K. Patel MD, MPH

Latest:

It Takes Two to TANGO With a Carbapenemase

Because of the global rise in antimicrobial resistance, meropenem-vaborbactam, the first carbapenem/β-lactamase combina­tion medication, is a welcome new antibac­terial.


Aislinn Antrim

Latest:

Texas Could Be Site of Next Large Measles Outbreak, Study Predicts

Texas could be the site of the next large measles outbreak in the United States, according to a new study that highlights the low vaccination rates among schools there.


SEAN BULLIS, MD

Latest:

Improving Vaccine Uptake in a Cohort of Patients With Asplenia

This is one of the first studies examining the effect of a dedicated postsplenectomy comprehensive clinic.


HELEN W. BOUCHER, MD

Latest:

Implications of the 21st Century Cures Act on Antibiotic Drug Development

Experts weigh in on what Congress is doing to tackle the threat of antibiotic resistance.


Carly Sedlock, MD

Latest:

COVID-19: How Temple University Hospital Is Addressing the Pandemic

The health system’s response could be used as a teaching model for addressing future infectious disease threats.


Sujit Suchindran, MD

Latest:

The Infectious Disease Physician's Holiday Wish List

For all you last-minute shoppers, Payal K. Patel MD, MPH, and Sujit Suchindran MD, have put together a wish list of the top items to get the infectious disease physician in your life.


Kelsey Fontneau, PharmD Candidate

Latest:

Women Living With HIV and Menopause: Bridging the Data Gap

Women living with HIV are at elevated risk for comorbidities as their life expectancy increases.


Bradley Langford, PharmD, BCPS*

Latest:

"Antibiotic Never Events": The Ideal Target to Reduce Antimicrobial Exposure

By stopping unnecessary antibiotics before they start, clinicians can avoid unnecessary harm to the patient and the population.


Alia Al-Tayyib, PhD, MSPH

Latest:

With the Opioid Epidemic, Communities See Dramatic Increases in Infectious Diseases

Rising incidence of viral and bacterial infections has accompanied the opioid crisis, but it also presents new opportunities for multidisciplinary treatment and preventive care.


MARGARET COOK, PHARMD, BCPS

Latest:

Antibiotic Prophylaxis Prior to Dental Procedures in Patients With Orthopedic Implants

Lingering historical concerns have led to inconsistent practices in antibiotic prophylaxis in this population.


JENNIFER ANDRES, PHARMD, BCPS

Latest:

Another Adverse Effect of the Opioid Epidemic: Hepatitis C Infections

An increase in injection drug use in the United States has augmented the likelihood of acquiring HCV, particularly genotype 3.


C Diff Foundation

Latest:

The C Diff Foundation Raises Clostridium difficile Infection (C difficile) Clinical Trial Awareness Worldwide

In the USA: Nearly half a million Americans suffer from Clostridium difficile (C. diff.) infections in a single year according to a study released in 2015 by the Centers for Disease Control and Prevention.


Joseph Eron, MD

Latest:

High-Resistance Therapy Options for Treatment-Naïve Patients With HIV

Joseph Eron, MD, Daniel R. Kuritzkes, MD, and Monica Gandhi, MD, MPH, discuss the likelihood of other combination regimens for the treatment of multidrug-resistant HIV, including monoclonal antibodies.


Adrienne Terico, PharmD, BCPS, BCIDP*

Latest:

It doesn’t get much beta than this: Novel beta-lactam antibiotics for multidrug-resistant gram-negative organisms

As the threat of infection with multidrug-resistant gram-negative organisms persists, new antimicrobials are a welcome addition to the armamentarium of infectious diseases clinicians.


AMY C. MIN, PHARMD, BCACP, AAHIVP

Latest:

DTG/3TC Offers Dual-Drug Therapy for Initial HIV Treatment

For the first time, patients with new HIV diagnoses have a 2-drug regimen option.


ESTHER KING, PHARMD*

Latest:

What's on Your Antimicrobial Stewardship "Wish List"?

If resources and funds were unlimited, what would the ideal stewardship program look like?


NAITIK PATEL, MD

Latest:

An Unknown Contagious Rash: Case Report and Literature Review of Norwegian Crusted Scabies

A patient with HIV and skin lesions should trigger a broad differential.


Alexandra Hanretty, PharmD*

Latest:

Employee Health After the COVID-19 Pandemic: Stronger Than Yesterday

For providers on the front lines, lessons learned can help inform strategies to enhance the protection of their health going forward.


MELISSA BADOWSKI, PHARMD, MPH, BCPS, AAHIVP

Latest:

Gender-Affirming Care in Persons Living With HIV

Gender-affirming hormone therapy (GAHT) therapy consists of administration of exogenous hormones and suppression of endogenous hormone production, with the goal of obtaining characteristics more congruent with an individual’s gender identity. Here is a review of these therapies and consideration for PrEP and the risks associated with HIV in this diverse population.


Catherine Li, PharmD, BCIDP

Latest:

A Penicillin Allergy Questionnaire for Outpatient Clinics

Clinicians developed an algorithm and screening questionnaire for outpatient penicillin allergy evaluation, designed to stratify patients into high- and low-risk penicillin allergy groups. Here is the sample questionnaire to consider for use in clinics.


ADRIENNE T. TERICO, PHARMD, BCPS

Latest:

A Peculiar Finding in an Unfamiliar Patient

A rare metallo-ß-lactamase makes its way into the United States via an 84-year-old patient.


Nimish Patel, PharmD, PHD, AAHIVP

Latest:

Summarizing SGLT-2 Inhibitor Usage in People With Diabetes and HIV

In persons living with HIV and diabetes, the management of diabetes is lagging behind the evidence. Despite SGLT-2 inhibitors demonstrating robust clinical data in the general population, they are grossly underused in persons with HIV and diabetes.


Jennifer S. Sun, PhD

Latest:

Can We Beat SARS-CoV-2? Lessons From Other Coronaviruses

A scientist who focuses on engineering bacteriophages for use as therapeutics shares thoughts on SARS-CoV-2.


ELIZABETH GANCHER, MD

Latest:

The Case of Late Aspergillus Fumigatus Infection of Implantable Cardioverter Defibrillator Leads

Quick action was needed against this very rare cause of fungal endocarditis.


MARY BANOUB, PHARMD

Latest:

New Initiatives for HIV Taking Off This Year

Advances in antiretroviral therapies increase opportunities for patients with HIV to have more successful treatment outcomes.


Rebecca Hoppe, MD

Latest:

Final Diagnosis: Disseminated Kaposi Sarcoma With Tonsillar and Pulmonary Involvement

A shocking find on a CT scan leads to an unexpected diagnosis.


AUSTIN WILLIAMS, PHARMD CANDIDATE

Latest:

Get Off the SOFA! Introducing the Quick Pitt Bacteremia Score

The quick Pitt Bacteremia Score offers accuracy comparable to the original version's across multiple infections, and maintains ease of use.


Jeannette Y. Wick, RPh, MBA, FASCP

Latest:

Aging Individuals With HIV Should Be Closely Monitored for Diabetes

Although antiretroviral therapy has led to significantly longer life expectancies among individuals with HIV, this, in turn, has contributed to the likelihood that these individuals will develop age-related comorbidities at earlier ages.

© 2025 MJH Life Sciences

All rights reserved.